Researchers from the Wyss Institute at Harvard University have developed a thrombosis-on-a-chip that can be used from drug development.
The development of this chip included, “engineering microfluidic culture devices with two parallel channels separated by a porous extracellular-matrix-coated membrane,” Lindsay Brownell writes in an article.
Click here to read.
An image of a thrombus (blood clot) formed on endothelial tissue in the Pulmonary Thrombosis-on-a-chip, demonstrating the characteristic “teardrop” shape observed in vivo. (Credit: Wyss Institute at Harvard University)
